BerandaNBY • NYSEAMERICAN
add
NovaBay Pharmaceuticals Inc
$0,63
Setelah Jam Perdagangan Normal:(3,26%)+0,021
$0,65
Tutup: 3 Jul, 14.06.54 GMT-4 · USD · NYSEAMERICAN · Pernyataan Penyangkalan
Tutup sebelumnya
$0,63
Rentang hari
$0,60 - $0,64
Rentang tahun
$0,36 - $2,45
Kapitalisasi pasar
3,63Â jt USD
Volume Rata-Rata
27,34Â rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 2,70Â jt | 17,90% |
Laba bersih | 7,67Â jt | 338,64% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -2,70Â jt | -18,43% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 8,47Â jt | 364,45% |
Total aset | 9,87Â jt | 84,28% |
Total liabilitas | 3,70Â jt | -28,71% |
Total ekuitas | 6,17 jt | — |
Saham yang beredar | 5,82 jt | — |
Harga terhadap nilai buku | 0,59 | — |
Tingkat pengembalian aset | -101,58% | — |
Tingkat pengembalian modal | -152,86% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Mar 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 7,67Â jt | 338,64% |
Kas dari operasi | 9,74Â jt | 1.476,41% |
Kas dari investasi | — | — |
Kas dari pembiayaan | -1,71Â jt | -186,10% |
Perubahan kas bersih | 8,04Â jt | 714,92% |
Arus kas bebas | 28,88Â rb | -97,37% |
Tentang
NovaBay Pharmaceuticals, Inc. is an Emeryville, California based clinical-stage biopharmaceutical company, focused on developing novel, fast-acting, synthetic anti-infectives compounds. These compounds are designed to mimic the body's defense system against infection. The company is currently focused on products for the eye care market. Major products include Avenova, cleared by FDA for lid and lash cleansing as part of a regimen for Blepharitis.
and NeutroPhase, used in treatment of Necrotizing Fasciitis Wikipedia
Didirikan
2000
Kantor pusat
Situs
Karyawan
14
